• Profile
Close

Peripheral blood intermediate monocyte protease-activated receptor-2 expression increases during asthma exacerbations and after inhalation allergen challenge

Annals of Allergy, Asthma, and Immunology May 25, 2021

Palikhe NS, Gandhi VD, Wu Y, et al. - Among persons with increased airway inflammation, either as a consequence of an asthma exacerbation or following an inhalation allergen challenge, this investigation was conducted to ascertain protease-activated receptor-2 (PAR-2: a proinflammatory serine protease receptor) expression on peripheral blood intermediate monocytes (IMMo). Patients with an asthma exacerbation, vs those with stable disease, were found to have increased PAR-2 expression in peripheral blood IMMo, but reduction in this expression was evident post-treatment of asthma exacerbation. An increment in percentages of IMMo expressing PAR-2, following an allergen challenge, was noted in participants with mild asthma. According to findings, elevated PAR-2 expression on monocytes during periods of increased airway inflammation may commence a positive feedback loop resulting in systemic inflammatory alterations.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay